BBG Advanced Therapies collects first cell donation on one-of-a-kind bus

Announcement: Expanded Capabilities with NEW Advanced Therapy Lab

BBG Advanced Therapies Subsidiary of BioBridge Global is advancing our role as an integrated partner for advanced therapy development by delivering cGMP-compliant umbilical cord tissue for further manufacturing—supported by the recently remodeled BBG Advanced Therapies Advanced Therapies Lab.

This enhancement strengthens infrastructure for controlled, aseptic processing within ISO-classified cleanroom environments, enabling scalable and compliant workflows aligned with global regulatory standards.

BBG Advanced Therapies provides a fully integrated model spanning:

  • Donor recruitment, screening, and IRB-approved consent
  • Birth tissue collection under controlled clinical protocols
  • Analytical and safety testing (sterility, mycoplasma, endotoxin)
  • cGMP-compliant processing, cryopreservation, and storage
Healthcare staff cutting ribbon at laboratory opening
Laboratory professionals celebrate the opening of a new lab space. A ribbon-cutting marks the expansion of integrated services.

Technical Applications for Therapy Developers:

  • Mesenchymal stromal cell (MSC) isolation and expansion
  • Extracellular vesicle (EV) and exosome production
  • iPSC derivation and downstream differentiation
  • Potency and characterization assay development

What functions does the Advanced Therapy Lab Support?

  • Operating the Texas Cord Blood Bank, including evaluation of cord blood donations and their storage
  • Supporting the BBG Advanced Therapies leukapheresis team, including testing and cryopreservation
  • Supporting third-party leukopak producers with cryopreservation   

However, consistent access to qualified, cGMP-grade starting material has historically limited scalability. BBG Advanced Therapies addresses this gap through its holistic, mission-driven approach, integrating starting materials, testing, and biomanufacturing into a single, coordinated system.

BBG Advanced Therapy Lab Key differentiators:

  • Integrated Quality Management System (QMS) ensuring identity, strength, safety, and purity
  • Purpose-built cleanrooms with unidirectional flow to minimize contamination risk
  • Expertise across preclinical, clinical, and commercial-stage support

By combining infrastructure, scientific expertise, and regulatory alignment, BBG Advanced Therapies enables therapy developers to move efficiently from starting material to clinical application—accelerating timelines while maintaining quality.

Connect with us on social media

Seeking Access to Starting Materials Contact Us